Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,045 | -8,868 | -4,537 | -20,781 | -14,906 |
| Depreciation Amortization | -158 | -124 | -67 | -221 | -167 |
| Other Working Capital | -206 | 451 | 69 | 2,228 | 915 |
| Other Operating Activity | 524 | 228 | 159 | 961 | 317 |
| Operating Cash Flow | $-12,885 | $-8,313 | $-4,376 | $-17,813 | $-13,841 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,763 | 6,834 | 3,241 | 3,382 | -68 |
| PPE Investments | -2 | -1 | -1 | -13 | -10 |
| Investing Cash Flow | $12,761 | $6,833 | $3,239 | $3,369 | $-78 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 972 | N/A | N/A | 67 | 67 |
| Financing Cash Flow | $972 | $N/A | $N/A | $67 | $67 |
| Exchange Rate Effect | 31 | 31 | 3 | -50 | 18 |
| Beginning Cash Position | 7,511 | 7,511 | 7,511 | 21,938 | 21,938 |
| End Cash Position | 8,390 | 6,061 | 6,378 | 7,511 | 8,103 |
| Net Cash Flow | $878 | $-1,450 | $-1,134 | $-14,427 | $-13,835 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,885 | -8,313 | -4,376 | -17,813 | -13,841 |
| Capital Expenditure | -2 | -1 | -1 | -13 | -10 |
| Free Cash Flow | -12,887 | -8,314 | -4,377 | -17,826 | -13,851 |